A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a

被引:44
|
作者
Spensberger, Dominik [1 ]
Delwel, Ruud [1 ]
机构
[1] Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands
关键词
Evi1; SUV39H1; G9a; histone methyltransferase; transcription; repression; AML;
D O I
10.1016/j.febslet.2008.06.056
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcription factor ecotropic viral integration site 1 (Evi1) is associated with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients due to chromosomal aberration of chromosome 3. Here we show that Evi1 interacts with the histone methyltransferase SUV39H1. The interaction requires the N-terminal part of Evi1 and the H3-specific histone methyltransferase domain, SET, of SUV39H1 without Evi1 having an inhibitory effect on SUV39H1 methyltransferase activity. Presence of SUV39H1 enhances Evi1 transcriptional repression in a dose dependent manner. In addition, Evi1 also interacts with another histone methyltransferase, G9a, but not with SET9. Our data establish an epigenetic role of Evi1 in cell transformation by recruiting higher order chromatin remodeling complexes. (c) 2008 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:2761 / 2767
页数:7
相关论文
共 50 条
  • [1] EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization
    S Goyama
    E Nitta
    T Yoshino
    S Kako
    N Watanabe-Okochi
    M Shimabe
    Y Imai
    K Takahashi
    M Kurokawa
    Leukemia, 2010, 24 : 81 - 88
  • [2] EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization
    Goyama, S.
    Nitta, E.
    Yoshino, T.
    Kako, S.
    Watanabe-Okochi, N.
    Shimabe, M.
    Imai, Y.
    Takahashi, K.
    Kurokawa, M.
    LEUKEMIA, 2010, 24 (01) : 81 - 88
  • [3] EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression
    Cattaneo, Francesca
    Nucifora, Giuseppina
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 105 (02) : 344 - 352
  • [4] Inhibition of histone methyltransferases SUV39H1 and G9a leads to neuroprotection in an in vitro model of cerebral ischemia
    Schweizer, Sophie
    Harms, Christoph
    Lerch, Heike
    Flynn, Jennifer
    Hecht, Jochen
    Yildirim, Ferah
    Meisel, Andreas
    Maerschenz, Stefanie
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2015, 35 (10): : 1640 - 1647
  • [5] EVI1 is a transcriptional repressor able to recruit SUV39H1 histone methylation activity.
    Cattaneo, Francesca
    Zakharov, Alexander
    Nucifora, Giuseppina
    BLOOD, 2007, 110 (11) : 373A - 374A
  • [6] A Subset of the Histone H3 Lysine 9 Methyltransferases Suv39h1, G9a, GLP, and SETDB1 Participate in a Multimeric Complex
    Fritsch, Lauriane
    Robin, Philippe
    Mathieu, Jacques R. R.
    Souidi, Mouloud
    Hinaux, Helene
    Rougeulle, Claire
    Harel-Bellan, Annick
    Ameyar-Zazoua, Maya
    Ait-Si-Ali, Slimane
    MOLECULAR CELL, 2010, 37 (01) : 46 - 56
  • [7] Histone Methyltransferases SUV39H1 and G9a and DNA Methyltransferase DNMT1 in Penumbra Neurons and Astrocytes after Photothrombotic Stroke
    Sharifulina, Svetlana
    Dzreyan, Valentina
    Guzenko, Valeria
    Demyanenko, Svetlana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [8] Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a
    Robin, Philippe
    Fritsch, Lauriane
    Philipot, Ophelie
    Svinarchuk, Fedor
    Ait-Si-Ali, Slimane
    GENOME BIOLOGY, 2007, 8 (12)
  • [9] Post-translational modifications of histones H3 and H4 associated with the histone methyltransferases Suv39h1 and G9a
    Philippe Robin
    Lauriane Fritsch
    Ophélie Philipot
    Fedor Svinarchuk
    Slimane Ait-Si-Ali
    Genome Biology, 8
  • [10] Overexpression of histone methyltransferases SUV39H1 and SUV39H2 in hepatocellular carcinoma
    Wong, Chun-Ming
    Ng, Irene
    CANCER RESEARCH, 2009, 69